EA Review #1, NDA 20-358 |
Page 17 |
ATTACHMENT 2 |
||||
|
SITE: |
Burroughs Wellcome Co.
(NC) |
||
|
FUNCTION: |
Manufacture of Drug
Substance, Formulation of Drug Product |
||
Description |
Permit # |
Exp. Date/ Renewal Date |
Applicable Emission Requirements |
Effect of Action on
Current Emissions Requirements |
All emission permits |
AQ-22 Permit No. 5754R48 |
1/1/96 |
North Carolina Dept. of
Environment, Health and Natural Resources Air Quality |
No adverse effect |
Wastewater |
Pretreatment Discharge Permit BW01-98 |
5/3/98 |
Greenville Utilities Commissions Publicly Owned Treatment Works |
No adverse effect |
Solid Waste Incinerator |
Incinerator 74-03-1 |
7/7/97 |
North Carolina Division of Solid Waste Permit |
No adverse effect |
Liquid Waste Incinerators |
NCD047373766 |
10/15/99 |
EPA and North Carolina (RCRA) |
No adverse effects |
Cooling Water Discharge |
NC001058 |
Expired, but effective while application is
pending |
National Pollutant Discharge Elimination System |
No adverse effect |
Back a Page
Next Page
Back to Wellbutrin SRŪ NDA Index Page
Back to Main
Index